New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
STAAR Surgical Company
STAA
Shape
US Flag

NASDAQ

2B

Medical - Instruments & Supplies

Next Earning date - 06 Nov 2024

2B

Medical - Instruments & Supplies

Next Earning date - 06 Nov 2024

34.16USD
Shape-1.52 ( -4.26%)
favorite-chart

Relative Strenght

77
favorite-chart

Volume Buzz

-38%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

35%

Quote Panel

Shape
Updated October 4, 2024
1W -8.05 % 1M 9.49 % 3M -23.97 % 1Y -9.82 %

Key Metrics

Shape
  • Market Cap

    1.68B


  • Shares Outstanding

    49.19M


  • Share in Float

    48.78M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    34.16


  • Average Volume

    824000


  • Beta

    0.597


  • Range

    26.66-52.68


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.staar.com


  • Sector

    Healthcare


Fundamentals

Shape

36.73x

P/E Ratio

5.27x

P/S Ratio

4.28x

P/B Ratio

0.1

Debt/Equity

5.0%

Net Margin

$0.3

EPS

How STAA compares to sector?

P/E Ratio

Relative Strength

Shape

STAA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$394M

Shape298%

2025-Revenue

$0.35

Shape133%

2025-EPS

$48M

Shape261%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Not converted

2024-07-15

Now: Underweight

William Blair

upgrade

Previous: Market Perform

2024-04-04

Now: Outperform

William Blair

downgrade

Previous: Not converted

2023-06-07

Now: Market Perform

Benchmark

upgrade

Previous: Not converted

2022-04-26

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+37%

0.37
vs 0.27

Q4.22

arrow
arrow

-37%

0.12
vs 0.19

Q1.23

arrow
arrow

N/A

0.18
vs NA

Q2.23

arrow
arrow

+38%

0.4
vs 0.29

Q3.23

arrow
arrow

-19%

0.3
vs 0.37

Q4.23

arrow
arrow

+100%

0.24
vs 0.12

Q1.24

arrow
arrow

-67%

0.06
vs 0.18

Q2.24

arrow
arrow

-17%

0.33
vs 0.4

Q3.24

arrow
arrow

-40%

0.18
vs 0.3

Q4.24

arrow
arrow

-64%

0.09
vs 0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+22%

76M  vs 62.4M

Q4.22

arrow
arrow

+9%

64M  vs 59M

Q1.23

arrow
arrow

NA

73.5M  vs NA

Q2.23

arrow
arrow

+46%

92.3M  vs 63.2M

Q3.23

arrow
arrow

+6%

80.3M  vs 76M

Q4.23

arrow
arrow

+19%

76.3M  vs 64M

Q1.24

arrow
arrow

+5%

77.4M  vs 73.5M

Q2.24

arrow
arrow

+7%

99M  vs 92.3M

Q3.24

arrow
arrow

+9%

87.2M  vs 80.3M

Q4.24

arrow
arrow

+5%

80.3M  vs 76.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+3%

0.03
vs 0.04

Q4.22

arrow
arrow

+2%

0.02
vs 0.03

Q1.23

arrow
arrow

+1%

0.01
vs 0.02

Q2.23

arrow
arrow

+2%

0.02
vs 0.01

Q3.23

arrow
arrow

+1%

0.01
vs 0.02

Q4.23

arrow
arrow

+2%

0.02
vs 0.01

Q1.24

arrow
arrow

-1%

-0.01
vs 0.02

Q2.24

arrow
arrow

+2%

0.02
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

316

316
vs 285

11%

Q4.22

arrow
arrow

289

289
vs 316

-9%

Q1.23

arrow
arrow

265

265
vs 289

-8%

Q2.23

arrow
arrow

262

262
vs 265

-1%

Q3.23

arrow
arrow

230

230
vs 262

-12%

Q4.23

arrow
arrow

219

219
vs 230

-5%

Q1.24

arrow
arrow

211

211
vs 219

-4%

Q2.24

arrow
arrow

231

231
vs 211

9%

Earnings Growth

Latest News